For patients with BMIs that started above 35, significant metabolic syndrome, or a history of yo-yo dieting, maintenance dosing often produces the best long-term outcomes
The greatest risk appears associated with prolonged use, with increased risks of 15- to 24-fold for 5 to 10 years or more, and this risk has been shown to persist for at least 8 to 15 years after estrogen therapy is discontinued
These are distinct physiological systems, but they are not entirely independent growth hormone has meaningful effects on glucose metabolism, insulin sensitivity, and fat distribution, which creates a potential area of overlap and interaction
For patients struggling to find weight loss success with diet and exercise alone, we offer provider supported weight management at locations across Long Island, New York
Understanding why this occurs and how to manage it can help you stay consistent with your weight loss journey